Clinical trials
Not yet recruiting Purpura, Thrombocytopenic, Idiopathic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2025 | 18 |
| 2026 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 9 |
| Institute of Hematology & Blood Diseases Hospital, China | 5 |
| Assiut University | 3 |
| Sohag University | 3 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 |
| University Hospital, Bordeaux | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Cullinan Therapeutics Inc. | 1 |
| Hellenic Society of Hematology | 1 |
| Jian Zhu | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 40 |
| Lupus Erythematosus, Systemic | 3 |
| Thrombocytopenia | 3 |
| Anemia | 1 |
| Anemia, Hemolytic | 1 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Antiphospholipid Syndrome | 1 |
| Autoimmune Diseases | 1 |
| Blood Platelet Disorders | 1 |
Trials
Showing 51 to 40 of 40. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.